Syndax Pharmaceuticals Inc (SNDX) › Weighted Average Diluted SharesSyndax Pharmaceuticals Inc (SNDX) — Weighted Average Diluted SharesAnnual figures by period end, from SEC filings.2019-12-31: 30.49M2020-12-31: 41.31M2021-12-31: 53.62M2022-12-31: 60.76M2023-12-31: 70.37M2024-12-31: 85.62M2025-12-31: 86.63M86.63M2019-12-31Weighted Average Diluted Shares (shares)2025-12-31Period endedWeighted Average Diluted SharesChange YoYSource filing2025-12-3186.63M+1.2%2026-02-26From 2025-01-012024-12-3185.62M+21.7%2026-02-26From 2024-01-012023-12-3170.37M+15.8%2026-02-26From 2023-01-012022-12-3160.76M+13.3%2025-03-03From 2022-01-012021-12-3153.62M+29.8%2024-02-27From 2021-01-012020-12-3141.31M+35.5%2023-02-28From 2020-01-012019-12-3130.49M—2022-03-01From 2019-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareEPS (Basic)